Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:32755570  

The MARCH6-SQLE Axis Controls Endothelial Cholesterol Homeostasis and Angiogenic Sprouting.

Josephine Mathilde Elisabeth Tan | Miesje Maxime van der Stoel | Marlene van den Berg | Nienke Marlies van Loon | Martina Moeton | Edwin Scholl | Nicole Neeltje van der Wel | Igor Kovačević | Peter Lodewijk Hordijk | Anke Loregger | Stephan Huveneers | Noam Zelcer
Cell reports | 2020

The endothelial monolayer forms a barrier between the lumen of blood vessels and the underlying tissues. Stable VE-cadherin-based adherens junctions are essential for maintaining this barrier, whereas their remodeling is required for angiogenesis in health and disease. Here, we position the ERAD-associated ubiquitin ligase MARCH6 as a determinant of angiogenic sprouting and barrier integrity through its ability to promote the degradation of the rate-limiting cholesterol biosynthetic enzyme squalene epoxidase (SQLE). Accordingly, MARCHF6 ablation in endothelial cells increases SQLE protein and cholesterol load. This leads to altered membrane order, disorganized adherens junctions, decreased endothelial barrier function, and impaired SQLE-dependent sprouting angiogenesis. Akin to MARCHF6 silencing, the overexpression of SQLE impairs angiogenesis. However, angiogenesis is also attenuated when SQLE is silenced, indicating that fine-tuning cholesterol biosynthesis is a determinant of healthy endothelial function. In summary, we propose a mechanistic link between regulation of cholesterol homeostasis by the MARCH6-SQLE axis and endothelial integrity and angiogenesis.

Pubmed ID: 32755570

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


HEK293T (tool)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

TEB4 Antibody (antibody)

RRID:AB_2621420

This unknown targets TEB4

View all literature mentions

SQLE antibody (antibody)

RRID:AB_2195888

This polyclonal targets SQLE

View all literature mentions

VE-Cadherin Polyclonal Antibody (antibody)

RRID:AB_10077705

This polyclonal targets VE-Cadherin

View all literature mentions

CD144 (antibody)

RRID:AB_10712766

This monoclonal targets CD144 (VE-Cadherin)

View all literature mentions

GM130 (D6B1) XP® Rabbit mAb (antibody)

RRID:AB_2797933

This monoclonal targets GM130

View all literature mentions

Anti-Actin Antibody, clone C4 (antibody)

RRID:AB_2223041

This monoclonal targets actin

View all literature mentions

HEK293T/17 (cell line)

RRID:CVCL_1926

Cell line HEK293T/17 is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions